Quantcast

Latest Johnson & Johnson Stories

2014-07-22 12:30:25

DUBLIN, July 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global IVD Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 IVDs are widely used to diagnose, monitor, and assess medical conditions, diseases, or infections usually in a controlled environment. IVD tests provide outcomes for earlier and more targeted treatment. These tests are minimally invasive, help reduce hospital stay, and provide accurate results....

2014-07-21 23:01:19

The firm is actively filing DePuy ASR lawsuits on behalf of those who have suffered metallosis, premature device failure, and other serious complications allegedly caused by the metal-on-metal hip device recalled in 2010. Rockville Centre, NY (PRWEB) July 21, 2014 Since November 19, 2013, when the parties announced a settlement of qualifying ASR cases, approximately 5,000 individual ASR patients whose cases were pending in the multidistrict litigation (MDL) have enrolled in the...

2014-07-21 23:01:09

The Firm is representing hundreds of women who allegedly suffered serious vaginal mesh complications due to pelvic mesh products manufactured by Ethicon, Inc. and other companies. New York, NY (PRWEB) July 21, 2014 The New Jersey Superior Court judge overseeing thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Ethicon Inc. has upheld the $11.1 million verdict awarded last year to the Plaintiff in the proceeding’s first bellwether trial....

2014-07-21 16:26:51

NEW BRUNSWICK, N.J., July 21, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has approved the repurchase of up to $5 billion of the company's common stock. Repurchases may be made at management's discretion from time to time on the open market or through privately negotiated transactions. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Any shares acquired will be available for...

2014-07-19 23:00:29

The Firm is representing several DePuy ASR lawsuit clients who allegedly suffered metallosis and other serious complications caused by the metal-on-metal design of the ASR Hip Replacement System. (PRWEB) July 19, 2014 A federal litigation that now includes more than 8,600 DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) has scheduled a meeting to discuss issues pertaining to claims involving the recalled metal-on-metal hip replacement, Bernstein Liebhard LLP reports....

2014-07-17 23:01:02

The Firm is actively investigating potential claims on behalf of patients who allegedly suffered Xarelto internal bleeding, strokes, pulmonary embolism and/or deep vein thrombosis following use of the blood thinner. New York, NY (PRWEB) July 17, 2014 Bernstein Liebhard LLP has launched a new website for individuals who may be eligible to file a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) alleging injuries caused by the new-generation blood thinner, the Firm reports. The site...

2014-07-15 23:01:47

The Firm is representing hundreds of women who were allegedly harmed by pelvic mesh devices manufactured by Ethicon, Inc. and other companies. New York, NY (PRWEB) July 15, 2014 Defendants in an Ethicon vaginal mesh lawsuit (http://www.transvaginalmeshlawsuithelp.com/) pending in the federal multidistrict litigation underway in the U.S. District Court, Southern District of West Virginia have been denied summary judgment on certain failure-to-warn claims contained in the complaint,...

2014-07-15 08:27:54

Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; NEW BRUNSWICK, N.J., July 15, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%. Domestic sales increased 14.9%. International sales increased 4.4%, reflecting operational growth of 5.0% and a...

2014-07-14 23:01:07

The Firm is representing hundreds of women who allegedly suffered serious vaginal mesh complications due to pelvic mesh products marketed by Ethicon, Inc. and other companies. New York, NY (PRWEB) July 14, 2014 The federal judge overseeing thousands of Ethicon transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) has ruled that plaintiffs in one case will be able to pursue certain claims involving the company’s use of a material called Prolene in some of its pelvic...

2014-07-14 08:26:29

Submission based on first head-to-head study vs. oral treatments in real world context TITUSVILLE, N.J., July 14, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking a label change that, if approved, would include new data showing significantly delayed time to relapse in patients prescribed once-monthly atypical long-acting antipsychotic INVEGA(®)...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related